Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Manageable levels of neuropathy in breast cancer patients receiving eribulin

Sep. 29, 2008

Cornerstone initiates CPI-613 trial for the treatment of cancer

Sep. 26, 2008

Belinostat in combination with carboplatin and paclitaxel evaluated in phase I/II cancer studies

Sep. 26, 2008

Preliminary results for AMG-386 in combination with other antiangiogenic agents in solid tumors

Sep. 26, 2008

New anticancer agents described in recent patents

Sep. 26, 2008

Studies show surfen to be a heparan sulfate antagonist

Sep. 26, 2008

Recent patent literature describes new anticancer agents

Sep. 23, 2008

[188Re]-HDD-lipiodol studied for hepatocellular carcinoma in Mongolia

Sep. 23, 2008

Abbott's ABT-869 shows activity against hepatocellular carcinoma in a phase II study

Sep. 23, 2008

Cleveland BioLabs awarded USD 13.3 million contract for Protectan CBLB-502

Sep. 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...